Investigating Micro-Manipulation Procedures for Assisted Hatching Timing

Recruiting N/A Interventional Study
Infertility
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 42
Sex
Female
Study type
Interventional
Purpose
Other
Participants needed
75 (estimated)
Sponsor
Reproductive Medicine Associates of New Jersey · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to assess the clinical significance of cleavage stage (Day 3) assisted hatching compared to assisted hatching at the blastocyst stage (Day 5,6,7) of embryo development at the time of trophectoderm (TE) biopsy for patients undergoing in vitro fertilization (IVF) and preimplantation genetic testing for aneuploidy (PGT-A) for treatment of their infertility.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for participants: 1. Patients undergoing an IVF cycle with plan for subsequent FET of a single euploid embryo 2. \<4 2PNs prior to randomization 3. Female partners age \<42 years old at start of VOR cycle 4. Normal ovarian reserve: 1. AMH ≥ 1.2 ng/mL 2. AFC ≥ 8 3. FSH ≤…
Contacts

Christine V Whitehead, MS, BSN, RN

19736562841

clinicalresearchteam@ivirma.com

CONTACT

Caroline Zuckerman, BS, RN

19736562841

clinicalresearchteam@ivirma.com

CONTACT